个人简介

Dr. Chloe Thio is a professor of medicine and an associate professor of molecular microbiology and immunology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include hepatitis, HIV/AIDS and infectious disease. Dr. Thio received her B.A. from the University of Pennsylvania. She earned her M.D. from the Yale University School of Medicine. She completed her residency at Hospital of the University of Pennsylvania and performed a fellowship in infectious diseases at Johns Hopkins. Her research interests include hepatitis and HIV/AIDS. Her recent research revealed that certain HIV drugs provide added benefit of protecting against hepatitis B. Dr. Thio serves on the Research Compensation Subcommittee for the Department of Medicine. She is a member of the American College of Physicians, the American Association for the Study of Liver Disease, the American Society of Clinical Investigation, HIVMA and the Infectious Diseases Society of America.

研究领域

Hepatitis B, hepatitis C, HIV

Dr. Thio has two primary research interests. The first is HIV-HBV co-infection, where she has projects in Nigeria, Australia and the United States. In addition, she is leading a multicenter international study looking at HIV-HBV co-infection within the ACTG framework. Her second area is on the human genetic determinants of HBV and HCV clearance, where she examines polymorphisms in human genes in persons that have either recovered from or have a persistent viral hepatitis infection.

近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Thio CL, Guo N, Xie C, Nelson KE, Ehrhardt S. "Global elimination of mother-to-child transmission of hepatitis B: Revisiting the current strategy." The Lancet Infectious Diseases. 2015;15(8):981-985. Ehrhardt S, Xie C, Guo N, Nelson KE, Thio CL. "Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: A review of the evidence." Clinical Infectious Diseases. 2015;60(2):275-278. Vergara C, Thio CL, Thomas D, Duggal P. "Polymorphisms in melanoma differentiation-associated gene 5 are not associated with clearance of hepatitis C virus in a European American population." Hepatology. 2015 Jun 23. doi: 10.1002/hep.27954. [Epub ahead of print]. Geller G, Dvoskin R, Thio CL, Duggal P, Lewis MH, Bailey TC, Sutherland A, Salmon DA, Kahn JP. "Genomics and infectious disease: A call to identify the ethical, legal and social implications for public health and clinical practice." Genome Med. 2014 Nov 18;6(11):106. doi: 10.1186/s13073-014-0106-2. eCollection 2014. Chun HM, Mesner O, Thio CT, Bebu I, Macalino G, Agan BK, Bradley WP, Malia J, Peel SA, Jagodzinski LL, et al.
"HIV outcomes in hepatitis B virus coinfected individuals on HAART." Journal of Acquired Immune Deficiency Syndromes. 2014;66(2):197-205.